Valley National Advisers’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320 Sell
3
-9
-75% -$1.09K ﹤0.01% 986
2026
Q1
$1K Sell
12
-38
-76% -$5.84K ﹤0.01% 831
2025
Q4
$8K Hold
50
﹤0.01% 638
2025
Q3
$7K Buy
+50
New +$6.13K ﹤0.01% 618
2025
Q2
Sell
-22
Closed -$1K 834
2025
Q1
$1K Hold
22
﹤0.01% 771
2024
Q4
$1K Hold
22
﹤0.01% 731
2024
Q3
$1K Sell
22
-10
-31% -$738 ﹤0.01% 699
2024
Q2
$2K Buy
+32
New +$1.24K ﹤0.01% 911

Other funds holding INSM

Valley National Advisers's INSM Position: Q2 2026 in Review

Valley National Advisers reduced its Insmed (INSM) stake by 75% in Q2 2026, selling an estimated $1.09K and leaving 3 shares worth $320. The position accounts for ﹤0.01% of the portfolio, ranked #986.

Valley National Advisers first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $8K in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Valley National Advisers held 3 shares of Insmed worth $320 as of Q2 2026.
  • Valley National Advisers sold 9 Insmed shares in Q2 2026, an estimated $1.09K.
  • Insmed made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #986 holding.
  • Valley National Advisers first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • Valley National Advisers's Insmed position peaked at $8K in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.